The global drugs for rheumatoid arthritis market size was USD 4,918.1 million in 2020. The COVID-19 pandemic has negatively affected several markets globally. This market is expected to grow positively during the pandemic. As per our research, the market is expected to grow at a CAGR of 8.87% during the forecast period. The sudden spike in CAGR is attributable to the market\'s growth and demand returning to pre-pandemic levels once the pandemic is over.

Drugs for rheumatoid arthritis are used to cure rheumatoid arthritis effectively. The rising demand for advanced medication is expected to bolster product demand. The prevalence of arthritis diseases is expected to boost the demand for advanced medical services. Increasing preferences for advanced healthcare solutions are expected to bolster demand for the product drastically. The demand for advanced medication is expected to boost product sales.

Increasing healthcare investments and demand for advanced treatment procedures are expected to bolster demand for the product. Increasing cases of arthritis are expected to bolster product demand. Evolving consumer preferences and demand for a healthy lifestyle are expected to boost demand. These factors are likely to influence the growth of the drugs for rheumatoid arthritis market development.